(CRVO) CervoMed - Performance -56.5% in 12m
CRVO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-79.08%
#131 in Peer-Group
Rel. Strength
7.31%
#7136 in Stock-Universe
Total Return 12m
-56.52%
#141 in Peer-Group
Total Return 5y
-89.85%
#115 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 19.77 USD |
| 52 Week Low | 1.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 57.40 |
| Buy/Sell Signal +-5 | 1.68 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CRVO (-56.5%) vs XBI (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.92% | 72.5% | 80.4% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.48% | -6.85% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.26% | -3.11% | 38.6% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.07% | 32.1% | -2.24% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.19% | -6.83% | 5.89% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.6% | 39.2% | -5% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.71% | 54.5% | -7.69% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.98% | 29.3% | 17.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CRVO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRVO
| Total Return (including Dividends) | CRVO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.21% | 4.28% | 4.37% |
| 3 Months | -24.89% | 17.36% | 14.09% |
| 12 Months | -56.52% | -6.86% | 13.68% |
| 5 Years | -89.85% | -21.19% | 112.88% |
| Trend Score (consistency of price movement) | CRVO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -88.1% | 13.1% | 83.6% |
| 3 Months | -88.9% | 79.4% | 97.2% |
| 12 Months | -65.1% | -87.1% | 45.7% |
| 5 Years | -71.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th17.00 | -17.73% | -17.81% |
| 3 Month | %th7.50 | -36.00% | -34.16% |
| 12 Month | %th30.00 | -53.31% | -61.75% |
| 5 Years | %th42.50 | -87.12% | -95.23% |
FAQs
Does CervoMed (CRVO) outperform the market?
No,
over the last 12 months CRVO made -56.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%.
Over the last 3 months CRVO made -24.89%, while XBI made 17.36%.
Performance Comparison CRVO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CRVO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 18.8% | -18.6% | 206.5% | -70% |
| US NASDAQ 100 | QQQ | 18.4% | -19.1% | 204.7% | -69% |
| German DAX 40 | DAX | 16.2% | -15.8% | 193.7% | -90% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 18.1% | -17.8% | 202.9% | -76% |
| Hongkong Hang Seng | HSI | 20.3% | -17.4% | 186.1% | -94% |
| India NIFTY 50 | INDA | 19.3% | -15% | 206% | -55% |
| Brasil Bovespa | EWZ | 22% | -18.1% | 188.3% | -61% |
CRVO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 19.8% | -18% | 202.4% | -81% |
| Consumer Discretionary | XLY | 19.9% | -16.8% | 215.1% | -73% |
| Consumer Staples | XLP | 21.1% | -14% | 207.5% | -64% |
| Energy | XLE | 18.1% | -20.4% | 213.5% | -59% |
| Financial | XLF | 19.8% | -17.3% | 203.2% | -84% |
| Health Care | XLV | 19.3% | -15.7% | 216.8% | -52% |
| Industrial | XLI | 18.3% | -18.1% | 199.9% | -82% |
| Materials | XLB | 19% | -18.6% | 203.4% | -64% |
| Real Estate | XLRE | 20.3% | -14% | 207.4% | -68% |
| Technology | XLK | 17.8% | -22% | 201.6% | -67% |
| Utilities | XLU | 18.6% | -16.4% | 204.8% | -79% |
| Aerospace & Defense | XAR | 17.7% | -18.9% | 188% | -107% |
| Biotech | XBI | 15.8% | -18.5% | 216.4% | -50% |
| Homebuilder | XHB | 18.2% | -23.5% | 211.6% | -64% |
| Retail | XRT | 19.4% | -16.3% | 212.7% | -68% |
CRVO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 17.7% | -21.0% | 219% | -53% |
| Natural Gas | UNG | 27.3% | 0% | 237.6% | -47% |
| Gold | GLD | 20.6% | -13.9% | 191.6% | -96% |
| Silver | SLV | 20.1% | -13% | 195.2% | -74% |
| Copper | CPER | 13% | -26% | 187.1% | -78% |
CRVO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 20.2% | -16.3% | 210.8% | -55% |
| iShares High Yield Corp. Bond | HYG | 19.6% | -15.8% | 209.6% | -66% |